Adamis Pharmaceuticals Provides Update on the U.S. Launch of SYMJEPI

World News: . []

SAN DIEGO Dec 06 2018 GLOBE NEWSWIRE -- NASDAQ ADMP today provided a business update announcing the US launch of FDA-approved SYMJEPI epinephrine 03mg Injection is planned for early Q1 2019Adamis has continued to work closely wi th Sand...

More news and information about Adamis Pharmaceuticals Corporation

Published By:

Globe Newswire: 14:30 GMT Thursday 6th December 2018

Published: .

Search for other references to "adamis" on SPi News


Share

Previous StoryNext Story

SPi News is published by Sector Publishing Intelligence Ltd.
© Sector Publishing Intelligence Ltd 2019. [Admin Only]
 
Sector Publishing Intelligence Ltd.
Agriculture House, Acland Road, DORCHESTER, Dorset DT1 1EF United Kingdom
Registered in England and Wales number 07519380.
 
Privacy Policy | Terms and Conditions | Contact Us